U.S. Renewable Energy Stock News

ARS Pharmaceuticals (SPRY) opened Q1 2026 with trailing 12 month revenue of about US$84.3 million and a reported loss of roughly US$171.3 million, translating to basic EPS of about US$1.74 loss, while the stock trades around US$7.43. Over recent quarters, the company has seen revenue move from US$7.97 million in Q1 2025 to US$28.09 million in Q4 2025, with basic EPS shifting from a loss of US$0.35 in Q1 2025 to a loss of US$0.42 in Q4 2025. This sets up a story where rising revenue is still...

ReposiTrak (TRAK) has reported Q3 2026 revenue of about US$5.9 million with basic EPS of roughly US$0.11, against a trailing 12 month EPS figure of about US$0.39 that reflects earnings growth of 11.5% over the past year and 17% per year over five years. Over recent quarters, the company has seen revenue move around the US$5.5 million to US$6.0 million range while quarterly EPS has tracked between roughly US$0.08 and US$0.11, supported by trailing 12 month net income of about US$7.1 million...

WEX (NYSE:WEX) has authorized a new $1b share repurchase program. The company has appointed David Foss as independent Chair, separating the Chair and CEO roles. WEX has reached a cooperation agreement with Impactive Capital that includes new board appointments and governance changes. The company has entered a partnership with Electric Era to expand fleet payment access to EV charging locations across the US. WEX, trading at $141.42, sits at the center of several material corporate decisions...

Schneider National (NYSE:SNDR) filed a shelf registration for an Employee Stock Ownership Plan related offering of approximately 19.9 million Class B shares. The filing covers up to US$610 million of securities that may be offered from time to time. The move centers on Class B common stock that is linked to employee ownership and incentive structures. Schneider National is a large North American trucking, intermodal, and logistics company, so any change in its equity structure tends to draw...

StoneCo (NasdaqGS:STNE) opened 2026 with Q1 revenue of R$3.6b and basic EPS of R$7.17, while trailing twelve month revenue stood at R$13.6b and EPS at R$14.00, framing a period where profitability has been firmly positive. Over the past year, the company has seen quarterly revenue move from R$3.2b in Q1 2025 to R$3.6b in Q1 2026, with basic EPS over those quarters ranging between R$1.83 and R$2.49 before stepping up to R$7.17 most recently. For investors, the key question now is how much of...

Pyxis Oncology (PYXS) has opened 2026 with Q1 results that keep the focus on scaling the top line while absorbing ongoing losses, with trailing 12 month revenue at about US$13.9 million and a basic EPS loss of roughly US$1.28 alongside net income losses of about US$79.6 million. Over recent quarters, the company has seen revenue move from US$0 in Q1 2025 to US$11.0 million in Q4 2025, while quarterly basic EPS losses have ranged between about US$0.29 and US$0.35 per share. For investors, that...

Investors may be wondering whether Alamo Group stock is starting to look appealing at current levels, or if the recent weakness is a warning sign. The share price has fallen 10.1% over the past week, 12.7% over the past month, and is down 27.0% over the last year. This naturally raises questions about how the risk and potential reward now stack up. Recent coverage has highlighted Alamo Group in the context of broader machinery and capital goods stocks, with attention on how companies in this...

Many investors are considering whether Golar LNG is fairly priced at its current level, or whether the stock still offers value for new money going in. The stock last closed at US$57.04, with returns of 2.4% over the past week, 6.0% over the past month, 50.3% year to date and 47.9% over the past year. These moves may have influenced how investors view its potential and risk. Recent coverage has focused on Golar LNG's positioning within the energy sector and on how investors are reacting to...

AVITA Medical (NasdaqCM:RCEL) opened Q1 2026 with revenue of US$19.3 million and a basic EPS loss of US$0.35, while trailing twelve month figures show revenue of US$72.3 million and a basic EPS loss of US$1.57. The company has seen quarterly revenue move from US$18.5 million in Q1 2025 to US$19.3 million in Q1 2026, alongside quarterly EPS losses shifting from US$0.53 to US$0.35. This keeps the focus firmly on how quickly margins can tighten and losses can be contained. See our full analysis...

Boston Omaha (BOC) opened 2026 with Q1 revenue of about US$28.2 million and a basic EPS loss of US$0.07, alongside a trailing 12 month EPS loss of US$0.44 on revenue of roughly US$114.9 million. This keeps the stock in loss making territory at a share price of US$11.06. Over the past six quarters, revenue has moved in a tight band between roughly US$27.7 million and US$29.7 million per quarter, while quarterly basic EPS has ranged from a profit of US$0.17 to a loss of US$0.22. This points to...

Sunrise Realty Trust (SUNS) opened Q1 2026 with total revenue of US$7.2 million and basic EPS of US$0.32, setting a clear marker for how the year is starting. The company reported quarterly revenue of US$4.5 million in Q1 2025 and US$7.2 million in Q1 2026, while basic EPS over the same quarters went from US$0.28 to US$0.32, giving you a clear view of how the top line and per share earnings have tracked over the past year. With trailing twelve month net margin and earnings growth already in...

Dillard's (DDS) has put up another solid quarter, with Q1 2027 revenue of US$1,588.6 million, basic EPS of US$16.06 and same store sales growth of 3%. Over the last few quarters, the company has seen revenue move from US$1,546.97 million in Q1 2026 to US$1,588.6 million in Q1 2027, while quarterly EPS has ranged from US$4.66 to US$16.06, giving investors a clear view of how sales and earnings are tracking together. Set against trailing 12 month EPS of US$42.10 and a net profit margin that has...

Shimmick (SHIM) has just posted Q1 2026 results that extend a mixed run of top line stability and bottom line pressure, with Q4 2025 revenue at US$100.4 million and basic EPS at a loss of US$0.08, compared with Q4 2024 revenue of US$103.6 million and a loss per share of US$1.13. Over the last reported quarters since Q1 2025, revenue has ranged between about US$100 million and US$166 million while quarterly EPS losses have moved between roughly US$0.05 and US$0.28, giving investors a clear...

Alliance Entertainment Holding (AENT) has put up another busy quarter, with Q2 2026 revenue at US$368.7 million and basic EPS of US$0.18, feeding into trailing 12 month revenue of about US$1.1 billion and EPS of US$0.43 as the latest reference points ahead of the Q3 2026 update. Over the past year, the company has seen revenue range between US$227.8 million and US$393.7 million per quarter while quarterly EPS moved between roughly US$0.01 and US$0.18. This gives investors a clearer read on...

Vistance Networks (NasdaqGS:VISN) has filed a new shelf registration for a sizable common stock offering. The filing includes an employee stock ownership plan, or ESOP, related component tied to common shares. The move signals potential changes to the company’s capital structure and employee equity participation that investors may want to monitor. For readers tracking NasdaqGS:VISN, this filing lands after a period of sharp share price swings. The stock closed at $11.37, with the price up...

Earlier in May 2026, Rigel Pharmaceuticals announced an exclusive global licensing agreement with Arvinas and Pfizer for VEPPANU (vepdegestrant), an FDA‑approved oral PROTAC for certain advanced or metastatic ER+/HER2-, ESR1‑mutated breast cancers. This deal makes VEPPANU Rigel’s fourth commercial product and the first approved PROTAC in its portfolio, potentially reshaping the company’s oncology focus and product mix. We’ll now examine how adding VEPPANU as a globally licensed, FDA‑approved...

In the first quarter of 2026, Venture Global, Inc. reported sales of US$4.60 billion and net income of US$598 million, with earnings per share exceeding analyst estimates and management lifting its 2026 consolidated Adjusted EBITDA guidance. At the same time, Venture Global secured new multi‑year LNG supply agreements with TotalEnergies and Vitol, adding over 1 million tonnes per year of contracted volumes that reinforce the company’s growing role in global LNG trade. Now we’ll examine how...

Abercrombie & Fitch (NYSE:ANF) has expanded its Your Personal Best (YPB) athleticwear line through a new partnership with NFL star TJ Watt. The company is launching an in store fan event featuring Watt, paired with a sweepstakes that brings shoppers into physical locations to engage with the YPB collection. For you as an investor watching NYSE:ANF, this move ties directly into how the company positions itself in casual and athletic apparel, a space where performance wear and lifestyle...

Karyopharm Therapeutics (KPTI) has opened Q1 2026 earnings season with revenue of about US$34.1 million in Q4 2025 and a basic EPS loss of US$5.71, providing a clear snapshot of a business still investing heavily for growth. Over recent quarters the company has seen revenue move between US$30.0 million and US$44.0 million, while basic EPS losses have ranged from roughly US$2.77 to US$5.71. This gives a tangible sense of how top line and per share results have been tracking into the latest...

Applied Materials (AMAT) has reported another busy quarter, with Q2 2026 revenue at US$7.9b and basic EPS of US$3.53, backed by net income excluding extra items of US$2.8b. The company has seen quarterly revenue move from US$7.1b and EPS of US$2.64 in Q2 2025 to US$7.9b and EPS of US$3.53 in Q2 2026, while trailing twelve month EPS sits at US$10.70 on net income of US$8.5b. This gives a sense of how profitability is feeding through the income statement and supporting higher margins. See our...

Recent performance snapshot Infinity Natural Resources (INR) has drawn investor attention after recent trading, with the stock closing at $15.40. Short term moves have been mixed, with a gain of 1.1% over the past day but a decline of 0.3% over the past week. Over the past month, the stock is down 1.6%, and over the past 3 months it is down 5.8%. Over the past year, the total return is down 12.6%, while year to date it is up 4.6%, highlighting a gap between recent momentum and longer term...

LanzaTech Global (LNZA) has put fresh numbers on the table for Q1 2026, with Q4 2025 revenue at US$28.0 million, Basic EPS at a loss of US$0.04, and net income excluding extra items showing a loss of US$0.08 million. The trailing twelve months to Q4 2025 recorded revenue of US$55.8 million, a Basic EPS loss of US$22.27, and a net loss of US$49.0 million. Over recent quarters, the company has seen revenue move from US$9.9 million in Q3 2024 to US$12.0 million in Q4 2024, then to US$9.5 million...

Hub Group (NasdaqGS:HUBG) has delayed recent SEC filings after identifying improperly recognized transactions in prior periods. The company plans to restate financial statements for 2023, 2024, and the first three quarters of 2025 to correct these accounting errors. The late filing notices and restatements mark a material financial reporting issue that could affect regulatory compliance and investor confidence. Hub Group operates in transportation and logistics, an area where efficient...

Jefferson Capital (JCAP) opened 2026 with Q1 revenue of US$176.4 million and basic EPS of US$0.68, while its trailing 12 month figures show revenue of US$628.8 million and EPS of US$2.58 alongside 29.6% revenue growth. Over recent quarters the company has seen revenue move from US$151.3 million in Q1 2025 to US$176.4 million in Q1 2026, with basic EPS ranging between US$0.58 and US$0.68 across the last four reported quarters. This sets up a picture where revenue expansion sits next to...